Found: 7
Select item for more details and to access through your institution.
Enhancement of the Local CD8 + T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens.
- Published in:
- Vaccines, 2021, v. 9, n. 11, p. 1273, doi. 10.3390/vaccines9111273
- By:
- Publication type:
- Article
IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11445, doi. 10.3390/ijms241411445
- By:
- Publication type:
- Article
Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7439, doi. 10.3390/ijms24087439
- By:
- Publication type:
- Article
Meglumine acridone acetate, the ionic salt of CMA and N-methylglucamine, induces apoptosis in human PBMCs via the mitochondrial pathway.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-54208-9
- By:
- Publication type:
- Article
Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine.
- Published in:
- PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0005984
- By:
- Publication type:
- Article
Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs.
- Published in:
- Microorganisms, 2021, v. 9, n. 4, p. 690, doi. 10.3390/microorganisms9040690
- By:
- Publication type:
- Article
TB/FLU-06E Influenza Vector-Based Vaccine in the Complex Therapy of Drug-Susceptible and Drug-Resistant Experimental Tuberculosis.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 7, p. 857, doi. 10.3390/pharmaceutics16070857
- By:
- Publication type:
- Article